Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03927069
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
EAH | (5S,7E,9E,11Z,14Z)-5-hydroxyicosa- 7,9,11,14-tetraenoic acid | A | 3DZT | 0.71 |  |
9OH | (TRANS-12,13-EPOXY)-9-HYDROXY-10(E)- OCTADECENOIC ACID | A | 1IK3 | 0.73 | |
RCL | RICINOLEIC ACID | A | 2CM4 | 0.74 | |
| RCL | RICINOLEIC ACID | A | 2CM9 | 0.74 | |
| RCL | RICINOLEIC ACID | A | 1FK7 | 0.74 | |
OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec- 9-enoate | A | 3D4S | 0.7 | |
8PG | (8S,12S)-15S-HYDROXY-9-OXOPROSTA- 10Z,13E-DIEN-1-OIC ACID | A,B | 2G5W | 0.81 | |
HNE | (2E,4R)-4-HYDROXYNON-2-ENAL | A,B | 2J3K | 0.72 | |
13R | 13(R)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID | A | 1IK3 | 0.8 | |
164 | 2-(3-CARBOXYPROPIONYL)-6-HYDROXY- CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID | A | 1R6W | 0.73 | |
OCX | (5E,11E,14E)-8-oxoicosa-5,9,11,14- tetraenoic acid | A,B | 2ZK3 | 0.75 | |
PG2 | PROSTAGLANDIN D2 | A,B | 1RY0 | 0.76 | |
HO2 | (9E,11E,13S)-13-hydroxyoctadeca- 9,11-dienoic acid | A | 3DBM | 0.82 | |
OXR | 4-OXORETINOL | A,B | 1X8L | 0.73 | |
6OB | (8E,10S,12Z)-10-hydroxy-6-oxooctadeca- 8,12-dienoic acid | A,B | 2VV4 | 0.82 | |
13S | 13(S)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID | A | 1IK3 | 0.8 | |
E2P | PROSTAGLANDIN B2 | A | 1CZ2 | 1 | |
6OC | (8R,9Z,12Z)-8-hydroxy-6-oxooctadeca- 9,12-dienoic acid | A,B | 2VV4 | 0.81 | |
ODT | (11E,13E,15Z)-OCTADECA-11,13,15- TRIENOIC ACID | A | 2BAC | 0.72 | |
OCR | (5E,8E,11Z,13E)-15-oxoicosa-5,8,11,13- tetraenoic acid | A,B | 2ZK4 | 0.76 | |
OPD | 9R,13R-12-OXOPHYTODIENOIC ACID | A,B | 1ICQ | 0.72 | |
AFB | 1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO- 1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN- 4-ONE | A,B,E | 1R8Q | 0.71 | |
| AFB | 1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO- 1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN- 4-ONE | A | 1RE0 | 0.71 | |
| AFB | 1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO- 1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN- 4-ONE | A,E | 1S9D | 0.71 | |
11O | (TRANS-12,13-EPOXY)-11-HYDROXY- 9(Z)-OCTADECENOIC ACID | A | 1IK3 | 0.71 | |
9HO | (9S,10E,12Z)-9-hydroxyoctadeca- 10,12-dienoic acid | A,B | 2VSR | 0.82 | |
MEI | (2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA- 2,4-DIENOIC ACID | A,B | 1UHL | 0.73 | |
4HD | (4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa- 5,7,10,13,16,19-hexaenoic acid | A,B | 2VV1 | 0.78 | |
5HE | (5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa- 6,8,11,14,17-pentaenoic acid | A,B | 2VV2 | 0.78 | |
ODD | (10E,12Z)-OCTADECA-10,12-DIENOIC ACID | A | 2BAB | 0.71 | |
T24 | (9Z,11E,13S,15Z)-13-hydroxyoctadeca- 9,11,15-trienoic acid | A,B | 3DSI | 0.82 | |
9OD | (2Z)-9-oxodec-2-enoic acid | A | 3BFA | 0.72 | |
| 9OD | (2Z)-9-oxodec-2-enoic acid | A,B | 3CZ0 | 0.72 | |
| 9OD | (2Z)-9-oxodec-2-enoic acid | A,B | 3CYZ | 0.72 | |
| 9OD | (2Z)-9-oxodec-2-enoic acid | A | 3BFB | 0.72 | |
PTG | (5E,14E)-11-oxoprosta-5,9,12,14- tetraen-1-oic acid | A,B | 2ZK1 | 0.77 | |
| PTG | (5E,14E)-11-oxoprosta-5,9,12,14- tetraen-1-oic acid | A | 2ZK2 | 0.77 | |
5OP | (5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA- 5,13-DIEN-1-OIC ACID | A | 2ZB4 | 0.74 | |
| 5OP | (5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA- 5,13-DIEN-1-OIC ACID | A,B | 1V3V | 0.74 | |
ASY | (12E)-10-oxooctadec-12-enoic acid | A,B | 3CEE | 0.71 | |
243 | (9Z,11E,13S)-13-hydroxyoctadeca- 9,11-dienoic acid | A,B | 3DSJ | 0.82 | |
| 243 | (9Z,11E,13S)-13-hydroxyoctadeca- 9,11-dienoic acid | A,B | 2RCH | 0.82 | |
| 243 | (9Z,11E,13S)-13-hydroxyoctadeca- 9,11-dienoic acid | A,B | 2VST | 0.82 | |